Accurate staging of non-metastatic colon cancer with CT: the importance of training and practice for experienced radiologists and analysis of incorrectly staged cases.


Journal

Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571

Informations de publication

Date de publication:
10 2022
Historique:
received: 24 03 2022
accepted: 25 05 2022
revised: 24 05 2022
pubmed: 8 7 2022
medline: 14 9 2022
entrez: 7 7 2022
Statut: ppublish

Résumé

To investigate whether locoregional staging of colon cancer by experienced radiologists can be improved by training and feedback to minimize the risk of over-staging into the context of patient selection for neoadjuvant therapy and to identify potential pitfalls of CT staging by characterizing pathologic traits of tumors that remain challenging for radiologists. Forty-five cases of stage I-III colon cancer were included in this retrospective study. Five experienced radiologists evaluated the CTs; 5 baseline scans followed by 4 sequential batches of 10 scans. All radiologists were trained after baseline scoring and 2 radiologists received feedback. The learning curve, diagnostic performance, reader confidence, and reading time were evaluated with pathologic staging as reference. Pathology reports and H&E slides of challenging cases were reviewed to identify potential pitfalls. Diagnostic performance in distinguishing T1-2 vs. T3-4 improved significantly after training and with increasing number of reviewed cases. Inaccurate staging was more frequently related to under-staging rather than over-staging. Risk of over-staging was minimized to 7% in batch 3-4. N-staging remained unreliable with an overall accuracy of 61%. Pathologic review identified two tumor characteristics causing under-staging for T-stage in 5/7 cases: (1) very limited invasive part beyond the muscularis propria and (2) mucinous composition of the invading part. The high accuracy and specificity of T-staging reached in our study indicate that sufficient training and practice of experienced radiologists can ensure high validity for CT staging in colon cancer to safely use neoadjuvant therapy without significant risk of over-treatment, while N-staging remained unreliable.

Identifiants

pubmed: 35798962
doi: 10.1007/s00261-022-03573-7
pii: 10.1007/s00261-022-03573-7
pmc: PMC9463303
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3375-3385

Informations de copyright

© 2022. The Author(s).

Références

AJR Am J Roentgenol. 2016 Nov;207(5):984-995
pubmed: 27490941
Diagn Interv Radiol. 2016 Jan-Feb;22(1):5-12
pubmed: 26611110
Br J Cancer. 2015 Jul 28;113(3):500-9
pubmed: 26068398
Cell Oncol. 2007;29(1):19-24
pubmed: 17429138
Abdom Radiol (NY). 2021 Sep;46(9):4096-4105
pubmed: 33904991
Colorectal Dis. 2016 Jan;18(1):73-9
pubmed: 26291535
Colorectal Dis. 2012 Apr;14(4):438-44
pubmed: 21689323
Nat Med. 2020 Apr;26(4):566-576
pubmed: 32251400
Chin J Cancer Res. 2016 Dec;28(6):598-605
pubmed: 28174488
Lancet Oncol. 2012 Nov;13(11):1152-60
pubmed: 23017669
Clin Transl Oncol. 2017 Mar;19(3):379-385
pubmed: 27496023
Eur J Surg Oncol. 2018 Sep;44(9):1354-1360
pubmed: 29914788
Ann Oncol. 2012 May;23(5):1198-1206
pubmed: 21948813
Acta Oncol. 2015 Nov;54(10):1747-53
pubmed: 25920359
Abdom Radiol (NY). 2021 Feb;46(2):476-485
pubmed: 32734351
BMC Cancer. 2020 Aug 18;20(1):776
pubmed: 32811457
Radiology. 2004 Apr;231(1):83-90
pubmed: 14990815
Abdom Radiol (NY). 2016 Oct;41(10):1877-90
pubmed: 27315073
Int J Colorectal Dis. 2018 Jan;33(1):9-17
pubmed: 29116438

Auteurs

S van de Weerd (S)

Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

E Hong (E)

Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Department of Radiology, Seoul National University Hospital, Seoul, South Korea.
GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.

I van den Berg (I)

Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

J W Wijlemans (JW)

Department of Radiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

J van Vooren (J)

Department of Radiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

M W Prins (MW)

Department of Radiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

F J Wessels (FJ)

Department of Radiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

B C Heeres (BC)

Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

S Roberti (S)

Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

J Nederend (J)

Department of Radiology, Catharina Hospital, Eindhoven, The Netherlands.

J H J M van Krieken (JHJM)

Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.

J M L Roodhart (JML)

Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

R G H Beets-Tan (RGH)

Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.

J P Medema (JP)

Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. j.p.medema@amsterdamumc.nl.
Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. j.p.medema@amsterdamumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH